Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
ACTIVE_NOT_RECRUITING
Status
Conditions
- Advanced Malignant Solid Neoplasm
- Carcinoma of Unknown Primary
- Metastatic Adrenal Gland Pheochromocytoma
- Metastatic Kidney Medullary Carcinoma
- Metastatic Malignant Germ Cell Tumor
- Metastatic Malignant Solid Neoplasm
- Metastatic Paraganglioma
- Metastatic Penile Carcinoma
- Metastatic Skin Squamous Cell Carcinoma
- Small Cell Carcinoma
- Stage III Adrenal Cortex Carcinoma AJCC v7
- Stage IV Adrenal Cortex Carcinoma AJCC v7
- Stage IV Penile Cancer AJCC v7
- Stage IV Renal Cell Cancer AJCC v7
- Unresectable Adrenal Gland Pheochromocytoma
- Unresectable Paraganglioma
- Unresectable Skin Squamous Cell Carcinoma
- Unresectable Solid Neoplasm
- Vascular Neoplasm
Interventions
- OTHER: Laboratory Biomarker Analysis
- BIOLOGICAL: Pembrolizumab
- OTHER: Questionnaire Administration
Sponsor
M.D. Anderson Cancer Center
Collaborators